drugset / Trial / NCT07364851

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

NCT07364851 ↗

Phase 1 Not yet recruiting 38 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelBasic science

Summary

Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1

Timeline

Start
2026-03-06
Primary completion
2026-05-30
Completion
2026-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject DW4421-T1 Unknown — —
Subject DW4421S-T1 Unknown — —

Indications

No indication recorded.